ACB
Aurora Cannabis, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.96
−0.75%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 53.09x
- P/E 2028E
- 24.47x
- P/S forward
- 1.13x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.67x
- Price / sales
- 1.22x
- Price / cash flow
- -12.61x
Enterprise value
- Enterprise value
- $161.2M
- EV / sales
- 0.78x
- EV / EBITDA
- -3.40x
- EV / EBIT
- -2.64x
- Market cap
- $250.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026